MARC details
000 -LEADER |
fixed length control field |
01360cam a22004218a 4500 |
001 - CONTROL NUMBER |
control field |
P 1998 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20140212102816.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
060710s2007 stk b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2006045095 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0443101078 (International ed.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0443101086 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780443101076 (International ed.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780443101083 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(DNLM)101281969 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DNLM/DLC |
Transcribing agency |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS200 |
Item number |
.A94-2007 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 785 |
Item number |
P5366 2007 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615/.19 |
Edition number |
22 |
245 00 - TITLE STATEMENT |
Title |
Pharmaceutics : |
Remainder of title |
the design and manufacture of medicines / |
Statement of responsibility, etc |
edited by Michael E. Aulton. |
250 ## - EDITION STATEMENT |
Edition statement |
3rd ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Edinburgh ; |
-- |
New York : |
Name of publisher, distributor, etc |
Churchill Livingstone, |
Date of publication, distribution, etc |
2007. |
263 ## - PROJECTED PUBLICATION DATE |
Projected publication date |
0706 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
p. ; |
Dimensions |
cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Design. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Dosage forms. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Dosage Forms. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Biopharmaceutics. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Design. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Aulton, Michael E. |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
orignew |
d |
1 |
e |
ocip |
f |
20 |
g |
y-gencatlg |
925 0# - |
-- |
acquire |
-- |
1 shelf copy |
-- |
policy default |
-- |
claim1 2010-02-12 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Book |
955 ## - COPY-LEVEL INFORMATION (RLIN) |
-- |
jc02 2006-07-19 |
-- |
jc02 2006-07-19 to Dewey |
963 ## - |
-- |
Jane Watson, bc: j.watson@elsevier.com |
985 ## - |
-- |
NLMCIP |
-- |
2006-07-14 |